Lixte Biotechnology Holdings Inc (LIXT)
2.89
+0.01
(+0.27%)
USD |
NASDAQ |
May 03, 16:00
2.89
0.00 (0.00%)
After-Hours: 20:00
Lixte Biotechnology Holdings Price: 2.89 for May 3, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 02, 2024 | 2.94 | 2.94 | 2.836 | 2.882 | 8657.00 |
May 01, 2024 | 2.89 | 2.92 | 2.85 | 2.88 | 7419.00 |
Apr 30, 2024 | 3.20 | 3.257 | 2.76 | 2.76 | 18682.00 |
Apr 29, 2024 | 3.24 | 3.24 | 3.10 | 3.14 | 6124.00 |
Apr 26, 2024 | 3.325 | 3.325 | 3.193 | 3.26 | 4162.00 |
Apr 25, 2024 | 3.26 | 3.40 | 3.105 | 3.22 | 14871.00 |
Apr 24, 2024 | 3.36 | 3.57 | 3.21 | 3.28 | 16082.00 |
Apr 23, 2024 | 3.30 | 3.54 | 3.11 | 3.22 | 40469.00 |
Apr 22, 2024 | 3.54 | 3.59 | 3.35 | 3.35 | 21756.00 |
Apr 19, 2024 | 3.460 | 3.535 | 3.33 | 3.465 | 11174.00 |
Apr 18, 2024 | 3.48 | 3.48 | 3.351 | 3.351 | 18311.00 |
Apr 17, 2024 | 3.47 | 3.50 | 3.25 | 3.33 | 12501.00 |
Apr 16, 2024 | 3.35 | 3.53 | 3.35 | 3.50 | 22066.00 |
Apr 15, 2024 | 3.42 | 3.48 | 3.28 | 3.30 | 18906.00 |
Apr 12, 2024 | 3.41 | 3.50 | 3.30 | 3.48 | 17466.00 |
Apr 11, 2024 | 3.46 | 3.505 | 3.33 | 3.38 | 17655.00 |
Apr 10, 2024 | 3.31 | 3.50 | 3.290 | 3.36 | 60050.00 |
Apr 09, 2024 | 3.34 | 3.65 | 3.17 | 3.31 | 136946.0 |
Apr 08, 2024 | 3.35 | 3.74 | 3.120 | 3.31 | 236044.0 |
Apr 05, 2024 | 3.21 | 3.46 | 3.18 | 3.20 | 54803.00 |
Apr 04, 2024 | 3.15 | 3.57 | 3.15 | 3.42 | 56884.00 |
Apr 03, 2024 | 3.40 | 3.80 | 3.10 | 3.10 | 126250.0 |
Apr 02, 2024 | 3.50 | 3.87 | 3.00 | 3.70 | 292009.0 |
Apr 01, 2024 | 3.27 | 3.60 | 2.900 | 3.57 | 332487.0 |
Mar 28, 2024 | 3.51 | 3.79 | 3.15 | 3.38 | 881270.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.73
Minimum
Jan 18 2024
81.00
Maximum
Aug 26 2019
28.03
Average
19.60
Median
Oct 04 2021
Price Benchmarks
iBio Inc | 1.96 |
PAVmed Inc | 2.10 |
PDS Biotechnology Corp | 3.825 |
Moleculin Biotech Inc | 5.00 |
Syros Pharmaceuticals Inc | 5.13 |
Price Related Metrics
Price to Book Value | 13.14 |
Earnings Yield | -93.43% |
Market Cap | 6.500M |